Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Grants Orphan Drug Designation to APR Applied Pharma Research's Investigational Drug for the Treatment of Epidermolysis Bullosa

biopharmadiveDecember 10, 2019

Tag: Food and Drug Administration , physiological , Applied Pharma Research

PharmaSources Customer Service